Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019_ randomised controlled trial Post author:Admin Post published:23 janvier 2021 Post category:COVID 19 Effect-of-tocilizumab-on-clinical-outcomes-at-15-days-in-patients-with-severe-or-critical-coronavirus-disease-2019_-randomised-controlled-trialTélécharger Vous devriez également aimer In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinicallyrelevant concentrations and timeframes using tissue culture and PCR based assays 2 février 2021 Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries_ a modelling study 30 décembre 2020 Covid et nne 10 février 2021
In vitro inactivation of SARS-CoV-2 with 0.5% povidone iodine nasal spray (Nasodine) at clinicallyrelevant concentrations and timeframes using tissue culture and PCR based assays 2 février 2021
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries_ a modelling study 30 décembre 2020
